Survey explores tough choices on blood thinners for End-of-Life patients
NCT ID NCT07486154
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study surveys 300 doctors to understand how they decide whether to continue or stop blood thinners in patients receiving palliative care. Using hypothetical cases, researchers aim to uncover patterns in these complex decisions. The study is observational and does not involve any drug or treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how doctors make tough choices about blood thinners in palliative care, potentially guiding future decision-making.
- What could go wrong
- This is a small, early survey study with no direct treatment. Results may not reflect real-world practice or apply to all settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PALLIATIVE CARE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, 00168, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Training healthcare teams to see the whole person behind the illness
- A 6-week coaching program may lift the weight on family caregivers — a study asks if it works.
- Can a simple text message transform cancer care?
- Can a 30-hour e-learning course equip family doctors to deliver better palliative care?
- Mushroom extract put to the test for advanced cancer Well-Being
- A simple lesson before discharge could ease the heavy load on family caregivers